Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 49 to 54 of 54 entries
Sorted by: Best Match Show Resources per page
The resting membrane potential of hSC-CM in a syncytium is more hyperpolarised than that of isolated cells.

Channels (Austin, Tex.)

Van de Sande DV, Kopljar I, Maaike A, Teisman A, Gallacher DJ, Bart L, Snyders DJ, Leybaert L, Lu HR, Labro AJ.
PMID: 33465001
Channels (Austin). 2021 Dec;15(1):239-252. doi: 10.1080/19336950.2021.1871815.

Human-induced pluripotent stem cell (hiPSC) and stem cell (hSC) derived cardiomyocytes (CM) are gaining popularity as in vitro model for cardiology and pharmacology studies. A remaining flaw of these cells, as shown by single-cell electrophysiological characterization, is a more...

Cite
Van de Sande DV, Kopljar I, Maaike A, et al. The resting membrane potential of hSC-CM in a syncytium is more hyperpolarised than that of isolated cells. Channels (Austin). 2021;15(1):239-252doi: 10.1080/19336950.2021.1871815.
Van de Sande, D. V., Kopljar, I., Maaike, A., Teisman, A., Gallacher, D. J., Bart, L., Snyders, D. J., Leybaert, L., Lu, H. R., & Labro, A. J. (2021). The resting membrane potential of hSC-CM in a syncytium is more hyperpolarised than that of isolated cells. Channels (Austin, Tex.), 15(1), 239-252. https://doi.org/10.1080/19336950.2021.1871815
Van de Sande, Dieter V, et al. "The resting membrane potential of hSC-CM in a syncytium is more hyperpolarised than that of isolated cells." Channels (Austin, Tex.) vol. 15,1 (2021): 239-252. doi: https://doi.org/10.1080/19336950.2021.1871815
Van de Sande DV, Kopljar I, Maaike A, Teisman A, Gallacher DJ, Bart L, Snyders DJ, Leybaert L, Lu HR, Labro AJ. The resting membrane potential of hSC-CM in a syncytium is more hyperpolarised than that of isolated cells. Channels (Austin). 2021 Dec;15(1):239-252. doi: 10.1080/19336950.2021.1871815. PMID: 33465001; PMCID: PMC7817136.
Copy Download .nbib Format: NLM
Connexin-Dependent Neuroglial Networking as a New Therapeutic Target.

Frontiers in cellular neuroscience

Charvériat M, Naus CC, Leybaert L, Sáez JC, Giaume C.
PMID: 28694772
Front Cell Neurosci. 2017 Jun 26;11:174. doi: 10.3389/fncel.2017.00174. eCollection 2017.

Astrocytes and neurons dynamically interact during physiological processes, and it is now widely accepted that they are both organized in plastic and tightly regulated networks. Astrocytes are connected through connexin-based gap junction channels, with brain region specificities, and those...

Cite
Charvériat M, Naus CC, Leybaert L, et al. Connexin-Dependent Neuroglial Networking as a New Therapeutic Target. Front Cell Neurosci. 2017;11:174doi: 10.3389/fncel.2017.00174.
Charvériat, M., Naus, C. C., Leybaert, L., Sáez, J. C., & Giaume, C. (2017). Connexin-Dependent Neuroglial Networking as a New Therapeutic Target. Frontiers in cellular neuroscience, 11174. https://doi.org/10.3389/fncel.2017.00174
Charvériat, Mathieu, et al. "Connexin-Dependent Neuroglial Networking as a New Therapeutic Target." Frontiers in cellular neuroscience vol. 11 (2017): 174. doi: https://doi.org/10.3389/fncel.2017.00174
Charvériat M, Naus CC, Leybaert L, Sáez JC, Giaume C. Connexin-Dependent Neuroglial Networking as a New Therapeutic Target. Front Cell Neurosci. 2017 Jun 26;11:174. doi: 10.3389/fncel.2017.00174. eCollection 2017. PMID: 28694772; PMCID: PMC5483454.
Copy Download .nbib Format: NLM
Efficacy and Safety of Lanreotide Autogel in the Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction: A Prospective Phase II Study.

Clinical therapeutics

Duck L, Demolin G, D'Hondt L, Dopchie C, Hendrickx K, Lannoye B, Bastin F, Lossignol D, Hamdan O, Lybaert W, Vandenhaute V, Regnault B, De Ruyter V, Geboes K.
PMID: 34844770
Clin Ther. 2021 Nov 26; doi: 10.1016/j.clinthera.2021.10.014. Epub 2021 Nov 26.

PURPOSE: Inoperable malignant intestinal obstruction (IMIO) is a severe complication in patients with cancer, usually gastrointestinal or gynecologic in origin. For patients with IMIO, there is a need to relieve symptoms and limit nasogastric tube (NGT) use. Previous studies...

Cite
Duck L, Demolin G, D'Hondt L, et al. Efficacy and Safety of Lanreotide Autogel in the Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction: A Prospective Phase II Study. Clin Ther. 2021;doi: 10.1016/j.clinthera.2021.10.014.
Duck, L., Demolin, G., D'Hondt, L., Dopchie, C., Hendrickx, K., Lannoye, B., Bastin, F., Lossignol, D., Hamdan, O., Lybaert, W., Vandenhaute, V., Regnault, B., De Ruyter, V., & Geboes, K. (2021). Efficacy and Safety of Lanreotide Autogel in the Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction: A Prospective Phase II Study. Clinical therapeutics, . https://doi.org/10.1016/j.clinthera.2021.10.014
Duck, Lionel, et al. "Efficacy and Safety of Lanreotide Autogel in the Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction: A Prospective Phase II Study." Clinical therapeutics vol. (2021). doi: https://doi.org/10.1016/j.clinthera.2021.10.014
Duck L, Demolin G, D'Hondt L, Dopchie C, Hendrickx K, Lannoye B, Bastin F, Lossignol D, Hamdan O, Lybaert W, Vandenhaute V, Regnault B, De Ruyter V, Geboes K. Efficacy and Safety of Lanreotide Autogel in the Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction: A Prospective Phase II Study. Clin Ther. 2021 Nov 26; doi: 10.1016/j.clinthera.2021.10.014. Epub 2021 Nov 26. PMID: 34844770.
Copy Download .nbib Format: NLM
The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories.

The European respiratory journal

Marcon A, Locatelli F, Dharmage SC, Svanes C, Heinrich J, Leynaert B, Burney P, Corsico A, Caliskan G, Calciano L, Gislason T, Janson C, Jarvis D, Jõgi R, Lytras T, Malinovschi A, Probst-Hensch N, Toren K, Casas L, Verlato G, Garcia-Aymerich J, Accordini S.
PMID: 33863744
Eur Respir J. 2021 Nov 25;58(5). doi: 10.1183/13993003.04656-2020. Print 2021 Nov.

Patients with concomitant features of asthma and chronic obstructive pulmonary disease (COPD) have a heavy disease burden.Using data collected prospectively in the European Community Respiratory Health Survey, we compared the risk factors, clinical history and lung function trajectories from...

Cite
Marcon A, Locatelli F, Dharmage SC, et al. The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories. Eur Respir J. 2021;58(5)doi: 10.1183/13993003.04656-2020.
Marcon, A., Locatelli, F., Dharmage, S. C., Svanes, C., Heinrich, J., Leynaert, B., Burney, P., Corsico, A., Caliskan, G., Calciano, L., Gislason, T., Janson, C., Jarvis, D., Jõgi, R., Lytras, T., Malinovschi, A., Probst-Hensch, N., Toren, K., Casas, L., Verlato, G., Garcia-Aymerich, J., Accordini, S. (2021). The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories. The European respiratory journal, 58(5), . https://doi.org/10.1183/13993003.04656-2020
Marcon, Alessandro, et al. "The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories." The European respiratory journal vol. 58,5 (2021). doi: https://doi.org/10.1183/13993003.04656-2020
Marcon A, Locatelli F, Dharmage SC, Svanes C, Heinrich J, Leynaert B, Burney P, Corsico A, Caliskan G, Calciano L, Gislason T, Janson C, Jarvis D, Jõgi R, Lytras T, Malinovschi A, Probst-Hensch N, Toren K, Casas L, Verlato G, Garcia-Aymerich J, Accordini S. The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories. Eur Respir J. 2021 Nov 25;58(5). doi: 10.1183/13993003.04656-2020. Print 2021 Nov. PMID: 33863744; PMCID: PMC8613837.
Copy Download .nbib Format: NLM
Correction to: Preservation of connexin 43 and transzonal projections in isolated bovine pre-antral follicles before and following vitrification.

Journal of assisted reproduction and genetics

Bus A, Szymanska K, Pintelon I, Leroy JLMR, Leybaert L, Bols PEJ.
PMID: 33331983
J Assist Reprod Genet. 2021 Feb;38(2):493. doi: 10.1007/s10815-020-02040-w.

No abstract available.

Cite
Bus A, Szymanska K, Pintelon I, et al. Correction to: Preservation of connexin 43 and transzonal projections in isolated bovine pre-antral follicles before and following vitrification. J Assist Reprod Genet. 2021;38(2):493doi: 10.1007/s10815-020-02040-w.
Bus, A., Szymanska, K., Pintelon, I., Leroy, J. L. M. R., Leybaert, L., & Bols, P. E. J. (2021). Correction to: Preservation of connexin 43 and transzonal projections in isolated bovine pre-antral follicles before and following vitrification. Journal of assisted reproduction and genetics, 38(2), 493. https://doi.org/10.1007/s10815-020-02040-w
Bus, Anniek, et al. "Correction to: Preservation of connexin 43 and transzonal projections in isolated bovine pre-antral follicles before and following vitrification." Journal of assisted reproduction and genetics vol. 38,2 (2021): 493. doi: https://doi.org/10.1007/s10815-020-02040-w
Bus A, Szymanska K, Pintelon I, Leroy JLMR, Leybaert L, Bols PEJ. Correction to: Preservation of connexin 43 and transzonal projections in isolated bovine pre-antral follicles before and following vitrification. J Assist Reprod Genet. 2021 Feb;38(2):493. doi: 10.1007/s10815-020-02040-w. PMID: 33331983; PMCID: PMC7884496.
Copy Download .nbib Format: NLM
Strategies to overcome relapse of immunotherapy-related hepatitis: dose reduction is not the key.

Acta clinica Belgica

Saerens M, Kruse V, Lybaert W.
PMID: 33754957
Acta Clin Belg. 2021 Mar 23;1-6. doi: 10.1080/17843286.2021.1903662. Epub 2021 Mar 23.

No abstract available.

Cite
Saerens M, Kruse V, Lybaert W. Strategies to overcome relapse of immunotherapy-related hepatitis: dose reduction is not the key. Acta Clin Belg. 2021;1-6doi: 10.1080/17843286.2021.1903662.
Saerens, M., Kruse, V., & Lybaert, W. (2021). Strategies to overcome relapse of immunotherapy-related hepatitis: dose reduction is not the key. Acta clinica Belgica, 1-6. https://doi.org/10.1080/17843286.2021.1903662
Saerens, Michael, et al. "Strategies to overcome relapse of immunotherapy-related hepatitis: dose reduction is not the key." Acta clinica Belgica vol. (2021): 1-6. doi: https://doi.org/10.1080/17843286.2021.1903662
Saerens M, Kruse V, Lybaert W. Strategies to overcome relapse of immunotherapy-related hepatitis: dose reduction is not the key. Acta Clin Belg. 2021 Mar 23;1-6. doi: 10.1080/17843286.2021.1903662. Epub 2021 Mar 23. PMID: 33754957.
Copy Download .nbib Format: NLM
Showing 49 to 54 of 54 entries